Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

Clinical trial NCT00626327 · COMPLETED

Trial details

NCT number: NCT00626327
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Infections

Start date: 2008-02-01
Primary completion: 2010-07-01
Enrollment: 1630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.